Company
Headquarters: Tarrytown, NY, United States
Founded: 1996
Employees: 505
CEO: Mr. Ronald M. Lombardi
$3.79 Billion
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $75.80 B |
Cencora, Inc. | $47.92 B |
Cardinal Health, Inc. | $31.29 B |
Henry Schein, Inc. | $9.32 B |
Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | $1.11 B |
EBITDA | $355.8 M |
Gross Profit TTM | $622.1 M |
Profit Margin | 18.54% |
Operating Margin | 29.72% |
Quarterly Revenue Growth | -0.90% |
Prestige Consumer Healthcare Inc. has the following listings and related stock indices.
Stock: NYSE: PBH wb_incandescent
Stock: FSX: PBV wb_incandescent